Fig. 1.Natural history of disease. Diagram illustrates that
preclinical phase begins at onset and ends when signs or symptoms develop.
Clinical phase then starts, ending with death. Detectable preclinical phase
(DPCP) begins when disease is detectable by a test. Detection (X) during DPCP
advances time of diagnosis by duration of lead time. (Reprinted from
[4])
Fig. 2.Lead-time bias. Diagram shows that, with screening, time of
diagnosis is advanced by lead time provided by positive test result. If
earlier diagnosis has no effect on time of death from disease, then survival
with testing is equal to survival without testing plus lead time. (Reprinted
from [4])
Fig. 3.Length-time bias. Diagram shows how probability of detection
is related to rate of disease progression. Length of each arrow represents
length of detectable preclinical phase, from initial detectability to clinical
diagnosis (Dx). Testing at a single moment detects four slowly progressive
cases but only two rapidly progressive cases. Cases not detected by test
(thin arrows) are diagnosed clinically either before or after time of
testing. Thick arrows indicate detected cases. (Reprinted from
[4])